Journal of Medical Physics
 Home | Search | Ahead of print | Current Issue | Archives | Instructions | Subscription | Login  The official journal of AMPI, IOMP and AFOMP      
 Users online: 83  Home  EMail this page Print this page Decrease font size Default font size Increase font size 
This article has been cited by
1Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy
Wiebke Sihver,Jens Pietzsch,Mechthild Krause,Michael Baumann,Jörg Steinbach,Hans-Jürgen Pietzsch
290Y/177Lu-labelled Cetuximab immunoconjugates: radiochemistry optimization to clinical dose formulation
Rubel Chakravarty,Sudipta Chakraborty,Haladhar Dev Sarma,K. V. Vimalnath Nair,Ardhi Rajeswari,Ashutosh Dash
Journal of Labelled Compounds and Radiopharmaceuticals.2016;59(9)354
3Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice
Wioletta Wojdowska,Urszula Karczmarczyk,Lajos Balog,Agnieszka Sawicka,Zita Pöstényi,Veronika Kovács-Haász,András Polyák,Ewa Laszuk,Renata Mikolajczak,Piotr Garnuszek
Cancer Biotherapy and Radiopharmaceuticals.2020;35(8)558
4Acute Rodent Tolerability, Toxicity, and Radiation Dosimetry Estimates of the S1P1-Specific Radioligand [11C]CS1P1
Hui Liu,Richard Laforest,Jiwei Gu,Zonghua Luo,Lynne A. Jones,Robert J. Gropler,Tammie L.S. Benzinger,Zhude Tu
Molecular Imaging and Biology.2020;22(2)285
5Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran
Amir Reza Jalilian,Davood Beiki,Arman Hassanzadeh-Rad,Arash Eftekhari,Parham Geramifar,Mohammad Eftekhari
Seminars in Nuclear Medicine.2016;46(4)340
  Search this journal
  Advance Search
  Editorial Board 
  The Journal 
  The Association 
  Contact Us 

Submit Articles